glp-1 obesity drug news today october 23 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth glp-1 obesity drug news today
Description
They modulate proliferation and overall promote osteogenesis while inhibiting adipogenesis
Injectable semaglutide was started at 0.25 mg once weekly Even though JMs A1C is fairly well controlled (7.1%), he has established ASCVD
Among these, parenteral held a significant share of 63.2%
2016;6:e208
An artificial intelligence (AI) analysis of over 400,000 Reddit posts found that people taking GLP-1 medications frequently report side effects not fully captured in clinical trials or drug labels
SUSTAIN-6 Investigators
